224 related articles for article (PubMed ID: 20874225)
1. Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model.
Wuyts WA; Willems S; Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Rinaldi M; Vanhooren HM; Geudens N; Verleden SE; Demedts MG; Thomeer M; Verbeken EK; Verleden GM
Exp Lung Res; 2010 Dec; 36(10):602-14. PubMed ID: 20874225
[TBL] [Abstract][Full Text] [Related]
2. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
[TBL] [Abstract][Full Text] [Related]
3. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
Cabrera S; Gaxiola M; Arreola JL; Ramírez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
[TBL] [Abstract][Full Text] [Related]
5. ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis.
Martins V; Valença SS; Farias-Filho FA; Molinaro R; Simões RL; Ferreira TP; e Silva PM; Hogaboam CM; Kunkel SL; Fierro IM; Canetti C; Benjamim CF
J Immunol; 2009 May; 182(9):5374-81. PubMed ID: 19380784
[TBL] [Abstract][Full Text] [Related]
6. 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis.
Gurrieri C; Piazza F; Gnoato M; Montini B; Biasutto L; Gattazzo C; Brunetta E; Cabrelle A; Cinetto F; Niero R; Facco M; Garbisa S; Calabrese F; Semenzato G; Agostini C
J Pharmacol Exp Ther; 2010 Mar; 332(3):785-94. PubMed ID: 19959748
[TBL] [Abstract][Full Text] [Related]
7. Generation of bleomycin-induced lung fibrosis is independent of IL-16.
Glass WG; Argentieri RL; Bracht M; Farrell FX; Das AM; Del Vecchio AM; Hogaboam CM; Murray LA
Cytokine; 2009 Apr; 46(1):17-23. PubMed ID: 19232499
[TBL] [Abstract][Full Text] [Related]
8. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injury.
Geudens N; Timmermans L; Vanhooren H; Vanaudenaerde BM; Vos R; Van De Wauwer C; Verleden GM; Verbeken E; Lerut T; Van Raemdonck DE
Transpl Int; 2008 Jul; 21(7):688-95. PubMed ID: 18435685
[TBL] [Abstract][Full Text] [Related]
11. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin.
Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F
Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102
[TBL] [Abstract][Full Text] [Related]
12. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
14. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
15. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
Gao JM; Lu B
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
[TBL] [Abstract][Full Text] [Related]
16. (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice.
Ren YX; Zhou R; Tang W; Wang WH; Li YC; Yang YF; Zuo JP
Acta Pharmacol Sin; 2007 Apr; 28(4):518-25. PubMed ID: 17376291
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.
Pardo A; Ruiz V; Arreola JL; Ramírez R; Cisneros-Lira J; Gaxiola M; Barrios R; Kala SV; Lieberman MW; Selman M
Am J Respir Crit Care Med; 2003 Mar; 167(6):925-32. PubMed ID: 12468440
[TBL] [Abstract][Full Text] [Related]
18. CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model.
Komura K; Yanaba K; Horikawa M; Ogawa F; Fujimoto M; Tedder TF; Sato S
Arthritis Rheum; 2008 Nov; 58(11):3574-84. PubMed ID: 18975313
[TBL] [Abstract][Full Text] [Related]
19. An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis.
Hu B; Ullenbruch MR; Jin H; Gharaee-Kermani M; Phan SH
J Pathol; 2007 Mar; 211(4):455-62. PubMed ID: 17177178
[TBL] [Abstract][Full Text] [Related]
20. Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosis.
Manoury B; Nénan S; Guénon I; Lagente V; Boichot E
Int Immunopharmacol; 2007 Jul; 7(7):900-11. PubMed ID: 17499192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]